Starbucks (SBUX) Shareholder Cobblestone Capital Advisors Has Trimmed Position as Stock Value Rose; Bank Of New York Mellon Trimmed Position in Novartis Ag (NVS) by $3.28 Million as Market Value Declined

June 19, 2018 - By Marguerite Chambers

Starbucks Corporation (NASDAQ:SBUX) Logo

Bank Of New York Mellon Corp decreased its stake in Novartis Ag (NVS) by 3.93% based on its latest 2018Q1 regulatory filing with the SEC. Bank Of New York Mellon Corp sold 41,001 shares as the company’s stock declined 11.54% with the market. The institutional investor held 1.00 million shares of the major pharmaceuticals company at the end of 2018Q1, valued at $80.94M, down from 1.04M at the end of the previous reported quarter. Bank Of New York Mellon Corp who had been investing in Novartis Ag for a number of months, seems to be less bullish one the $189.86 billion market cap company. The stock decreased 0.70% or $0.52 during the last trading session, reaching $73.57. About 3.01 million shares traded or 79.87% up from the average. Novartis AG (NYSE:NVS) has declined 6.45% since June 19, 2017 and is downtrending. It has underperformed by 19.02% the S&P500. Some Historical NVS News: 06/05/2018 – Mint: Aurobindo launches $1.6 billion bid to buy Novartis generics unit; 10/05/2018 – For all I know, $NVS Joe Jimenez really was responsible for the Cohen mess — but doesn’t it strike anyone else as just oh so convenient that insiders are sticking a knife in his back to PVAAC: Protect Vas At All Costs?; 07/05/2018 – Novartis: Alcon Cares Project 100 Commits to Reducing Cataract Blindness Globally; 16/05/2018 – Novartis: Counsel Resigns Over Company’s Michael Cohen Deal; 18/05/2018 – Novartis, Amgen: Aimovig Is Migraine Prevention Drug; 17/05/2018 – Novartis and Amgen Announce FDA Approval of Aimovig for Migraine Prevention; 05/04/2018 – AbbVie Announces Global Resolution of HUMIRA® (adalimumab) Patent Disputes with Samsung Bioepis; 09/05/2018 – DURECT CORP – AMENDMENT ALSO INCLUDES MODIFICATIONS TO DURECT’S DEVELOPMENT OBLIGATIONS AND TO BOTH PARTIES’ TERMINATION PROVISIONS; 10/04/2018 – MOODY’S SAYS $8.7 BILLION ACQUISITION OF AVEXIS STRENGTHENS NOVARTIS’S PIPELINE IN GENE THERAPY, BUT REDUCES FINANCIAL FLEXIBILITY; 28/05/2018 – NOVARTIS: IMPROVEMENT IN QUALITY OF LIFE DOMAINS WITH ENTRESTO®

Cobblestone Capital Advisors Llc decreased its stake in Starbucks Corp (SBUX) by 82.55% based on its latest 2018Q1 regulatory filing with the SEC. Cobblestone Capital Advisors Llc sold 85,427 shares as the company’s stock rose 1.31% while stock markets declined. The hedge fund held 18,060 shares of the restaurants company at the end of 2018Q1, valued at $1.05M, down from 103,487 at the end of the previous reported quarter. Cobblestone Capital Advisors Llc who had been investing in Starbucks Corp for a number of months, seems to be less bullish one the $79.25B market cap company. The stock increased 0.37% or $0.21 during the last trading session, reaching $57.43. About 7.00 million shares traded. Starbucks Corporation (NASDAQ:SBUX) has declined 7.92% since June 19, 2017 and is downtrending. It has underperformed by 20.49% the S&P500. Some Historical SBUX News: 01/05/2018 – Starbucks adds 2 new Frappuccinos to its permanent menu; 07/05/2018 – The $7.15 billion deal with food giant Nestle will help Starbucks return value to its shareholders; 26/04/2018 – STARBUCKS CORP – ANNOUNCES ADDITIONAL 100M SHARE REPURCHASE AUTHORIZATION; 26/04/2018 – Starbucks’ Americas cafe sales rise more than expected; 19/04/2018 – ABC7 News: .@ABC News Exclusive: Men arrested at Philly #Starbucks say they did nothing wrong, feared for their live; 18/04/2018 – May 29 will mark the second time that Starbucks has closed its stores for an afternoon; 17/04/2018 – Starbucks Plans Racial-Bias Training for Employees at U.S. Stores; 29/05/2018 – ♫ Reuters Insider – JAB buys majority stake in UK’s Pret a Manger; 26/04/2018 – SBUX SAYS OPENING PRINCI STORES ACROSS THE GLOBE; 27/04/2018 – Starbucks CEO says Philadelphia arrests has not hurt sales in April

Bank Of New York Mellon Corp, which manages about $361.31B US Long portfolio, upped its stake in Loxo Oncology Inc (NASDAQ:LOXO) by 17,298 shares to 122,529 shares, valued at $14.14M in 2018Q1, according to the filing. It also increased its holding in Byline Bancorp Inc by 30,235 shares in the quarter, for a total of 47,471 shares, and has risen its stake in Avnet Inc (NYSE:AVT).

More important recent Novartis AG (NYSE:NVS) news were published by: Seekingalpha.com which released: “Novartis’ Kymriah shows sustained benefit in DLBCL patients” on June 18, 2018, also Seekingalpha.com published article titled: “Novartis: Exit Sandoz US Now”, Streetinsider.com published: “Novartis (NVS) Granted FDA Approval for Inclusion of New Evidence that Cosentyx (secukinumab) Inhibits Progression …” on June 19, 2018. More interesting news about Novartis AG (NYSE:NVS) was released by: Seekingalpha.com and their article: “Breaking Down Barriers: BiOasis Technologies Promises Breakthrough Brain Drug Delivery” with publication date: June 19, 2018.

Analysts await Novartis AG (NYSE:NVS) to report earnings on July, 17. They expect $1.31 earnings per share, up 8.26% or $0.10 from last year’s $1.21 per share. NVS’s profit will be $3.38B for 14.04 P/E if the $1.31 EPS becomes a reality. After $1.28 actual earnings per share reported by Novartis AG for the previous quarter, Wall Street now forecasts 2.34% EPS growth.

Among 17 analysts covering Novartis Ag (NYSE:NVS), 5 have Buy rating, 3 Sell and 9 Hold. Therefore 29% are positive. Novartis Ag had 38 analyst reports since July 28, 2015 according to SRatingsIntel. On Wednesday, October 25 the stock rating was downgraded by Barclays Capital to “Sell”. Leerink Swann maintained the stock with “Hold” rating in Thursday, June 22 report. The firm has “Neutral” rating given on Friday, March 24 by JP Morgan. Leerink Swann downgraded Novartis AG (NYSE:NVS) on Wednesday, March 23 to “Market Perform” rating. As per Tuesday, March 29, the company rating was downgraded by Citigroup. The stock of Novartis AG (NYSE:NVS) earned “Buy” rating by Chardan Capital Markets on Tuesday, September 20. The firm has “Overweight” rating given on Wednesday, July 26 by Morgan Stanley. Cowen & Co maintained the stock with “Hold” rating in Monday, September 11 report. The stock of Novartis AG (NYSE:NVS) earned “Underperform” rating by Mainfirst on Wednesday, October 28. Bank of America downgraded the shares of NVS in report on Wednesday, December 6 to “Sell” rating.

Among 37 analysts covering Starbucks Corporation (NASDAQ:SBUX), 23 have Buy rating, 0 Sell and 14 Hold. Therefore 62% are positive. Starbucks Corporation had 108 analyst reports since July 28, 2015 according to SRatingsIntel. Goldman Sachs maintained Starbucks Corporation (NASDAQ:SBUX) rating on Friday, July 22. Goldman Sachs has “Buy” rating and $69 target. The firm has “Hold” rating by BMO Capital Markets given on Tuesday, October 3. The firm has “Buy” rating by Deutsche Bank given on Monday, May 15. UBS maintained Starbucks Corporation (NASDAQ:SBUX) rating on Wednesday, June 28. UBS has “Buy” rating and $7000 target. Vetr downgraded the stock to “Strong-Buy” rating in Friday, August 28 report. Stephens maintained Starbucks Corporation (NASDAQ:SBUX) on Friday, July 28 with “Hold” rating. Goldman Sachs maintained it with “Buy” rating and $72 target in Wednesday, May 4 report. Mizuho maintained the shares of SBUX in report on Thursday, September 28 with “Buy” rating. The rating was maintained by Wedbush with “Outperform” on Friday, July 22. Deutsche Bank downgraded Starbucks Corporation (NASDAQ:SBUX) on Tuesday, April 12 to “Hold” rating.

Analysts await Starbucks Corporation (NASDAQ:SBUX) to report earnings on July, 26. They expect $0.65 earnings per share, up 18.18% or $0.10 from last year’s $0.55 per share. SBUX’s profit will be $897.00M for 22.09 P/E if the $0.65 EPS becomes a reality. After $0.53 actual earnings per share reported by Starbucks Corporation for the previous quarter, Wall Street now forecasts 22.64% EPS growth.

Since January 31, 2018, it had 0 insider purchases, and 3 selling transactions for $13.62 million activity. $9.28M worth of Starbucks Corporation (NASDAQ:SBUX) shares were sold by BURROWS CLIFFORD. $740,851 worth of Starbucks Corporation (NASDAQ:SBUX) shares were sold by ULLMAN MYRON E III.

More notable recent Starbucks Corporation (NASDAQ:SBUX) news were published by: Nasdaq.com which released: “Starbucks Without Howard Schultz Is Still a Buy” on June 19, 2018, also Usatoday.com with their article: “Starbucks tops Apple in mobile payments: A Foolish Take” published on June 16, 2018, Seekingalpha.com published: “Starbucks lifts coffee prices in the US” on June 07, 2018. More interesting news about Starbucks Corporation (NASDAQ:SBUX) were released by: Seekingalpha.com and their article: “Ep. 65: What’s Behind The Newest Revolution In Coffee” published on June 19, 2018 as well as Seekingalpha.com‘s news article titled: “Anti-bias training day at Starbucks” with publication date: May 29, 2018.

Cobblestone Capital Advisors Llc, which manages about $1.26B and $987.31 million US Long portfolio, upped its stake in General Electric Co (NYSE:GE) by 99,184 shares to 530,271 shares, valued at $7.15 million in 2018Q1, according to the filing. It also increased its holding in Gilead Sciences Inc (NASDAQ:GILD) by 4,134 shares in the quarter, for a total of 66,399 shares, and has risen its stake in Disney Walt Co (NYSE:DIS).

Investors sentiment decreased to 0.93 in Q1 2018. Its down 0.12, from 1.05 in 2017Q4. It dived, as 61 investors sold SBUX shares while 485 reduced holdings. 118 funds opened positions while 391 raised stakes. 955.12 million shares or 2.87% less from 983.38 million shares in 2017Q4 were reported. Motley Fool Asset Ltd Liability Company owns 208,272 shares. The Germany-based Dekabank Deutsche Girozentrale has invested 0.36% in Starbucks Corporation (NASDAQ:SBUX). Hengehold Cap Management Ltd Liability invested in 0.12% or 7,685 shares. Smart Portfolios Limited Liability Corp holds 5,720 shares or 0.22% of its portfolio. D Scott Neal invested in 1,000 shares. Creative Planning reported 250,722 shares or 0.06% of all its holdings. 35,116 are owned by Amarillo Bancshares. Buffington Mohr Mcneal owns 7,491 shares or 0.17% of their US portfolio. 3,809 were accumulated by Brookstone Management. Prentiss Smith Inc owns 1,200 shares for 0.04% of their portfolio. State Of New Jersey Common Pension Fund D, a New Jersey-based fund reported 120,000 shares. Meyer Handelman holds 0.21% in Starbucks Corporation (NASDAQ:SBUX) or 72,080 shares. Cap Fund Management Sa owns 0.01% invested in Starbucks Corporation (NASDAQ:SBUX) for 39,348 shares. Atwood And Palmer invested in 200 shares. Prescott Group Inc Ltd Liability Co accumulated 17,200 shares.

Starbucks Corporation (NASDAQ:SBUX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts

>